<DOC>
	<DOCNO>NCT00143273</DOCNO>
	<brief_summary>To establish optimal dose lasofoxifene fully effective increase BMD postmenopausal Asian woman .</brief_summary>
	<brief_title>Dose Response Study Lasofoxifene Postmenopausal Women With Osteoporosis - Japanese Asian Dose Evaluation</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<criteria>postmenopausal Asian woman osteoporosis define low BMD Metabolic bone disease , use osteoporosis drug drug interering normal bone metabolism</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>